Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2013 | 1 |
2014 | 1 |
2015 | 1 |
2016 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal.
Front Oncol. 2015 Feb 16;5:34. doi: 10.3389/fonc.2015.00034. eCollection 2015.
Front Oncol. 2015.
PMID: 25763356
Free PMC article.
Review.
Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.
Linch SN, Kasiewicz MJ, McNamara MJ, Hilgart-Martiszus IF, Farhad M, Redmond WL.
Linch SN, et al.
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E319-27. doi: 10.1073/pnas.1510518113. Epub 2016 Jan 4.
Proc Natl Acad Sci U S A. 2016.
PMID: 26729864
Free PMC article.
Item in Clipboard
Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.
Redmond WL, Triplett T, Floyd K, Weinberg AD.
Redmond WL, et al.
PLoS One. 2012;7(4):e34467. doi: 10.1371/journal.pone.0034467. Epub 2012 Apr 4.
PLoS One. 2012.
PMID: 22496812
Free PMC article.
Item in Clipboard
Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.
Redmond WL, Linch SN, Kasiewicz MJ.
Redmond WL, et al.
Cancer Immunol Res. 2014 Feb;2(2):142-53. doi: 10.1158/2326-6066.CIR-13-0031-T. Epub 2013 Nov 11.
Cancer Immunol Res. 2014.
PMID: 24778278
Free PMC article.
Item in Clipboard
Cite
Cite